PDS Biotechnology Corp - Common Stock, par value $0.00033 per share (PDSB)

CUSIP: 70465T107

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 7 signals
Share change
-54,643
Put/Call ratio
20%
SEC-reported price per share
$6.19
Number of holders
49
Value change
-$1,228,374
Number of buys
25
Open additional details 1 more signal available
Number of sells
30
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
102,192,638

Security key

70465T107

Report period

Q1 2022

Institutions

49

Top holders

10

Ownership snapshot

Top reported holders of PDSB - PDS Biotechnology Corp - Common Stock, par value $0.00033 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
31 Dec 2021
13F 3/4/5 Highest disclosed value: $8,220,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $8.22M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value Top 5
VANGUARD GROUP INC $8.22M
DeLyle W. Bloomquist $7.81M
TWO SIGMA ADVISERS, LP $4.27M
TWO SIGMA INVESTMENTS, LP $3.91M
RENAISSANCE TECHNOLOGIES LLC $3.6M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$8,220,000
1,014,860 shares
— 31 Dec 2021
DeLyle W. Bloomquist
3/4/5
Resigned as a Director on June 17, 2021.
—
mixed-class rows
$7,813,350
804,941 shares
mixed-class rows
— 16 Jun 2021
TWO SIGMA ADVISERS, LP
13F
Company
13F
—
denominator unverified
$4,268,000
526,900 shares
— 31 Dec 2021
TWO SIGMA INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$3,906,000
482,166 shares
— 31 Dec 2021
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$3,602,000
444,737 shares
— 31 Dec 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$3,495,000
431,405 shares
— 31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
49
Shares
5,851,637
Rows available
49
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders
49
Q1 2022 holders
49
Holder diff
0
Investor Q1 2022 Shares Q1 2022 Shares Share Diff Share Chg % Q1 2022 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .